Testing effectiveness (Phase 2)Study completedNCT04739865
What this trial is testing
The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression
Who this might be right for
Treatment Resistant Depression
COMPASS Pathways 19